Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Uterine Infusion Preceding Frozen Embryo Transfer
NCT06621342Phase 2Withdrawn
- Sponsor
- University of Kansas Medical Center
- Start
- Feb 2023
- Primary completion
- Feb 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous platelet-rich plasma in infertility and endometriosis (2 arms), sponsored by University of Kansas Medical Center. Primary endpoint: Concentrations of factors critical to the implantation process at 18 months. Planned start Feb 2023; status: withdrawn.
02
Drugs
autologous platelet-rich plasma
03
Conditions
infertilityendometriosis
Beyond the preview
Go deeper on NCT06621342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06621342.